240 related articles for article (PubMed ID: 10188844)
21. PD-1, S-100 and CD1a expression in pseudolymphomatous folliculitis, primary cutaneous marginal zone B-cell lymphoma (MALT lymphoma) and cutaneous lymphoid hyperplasia.
Goyal A; Moore JB; Gimbel D; Carter JB; Kroshinsky D; Ferry JA; Harris NL; Duncan LM
J Cutan Pathol; 2015 Jan; 42(1):6-15. PubMed ID: 25384543
[TBL] [Abstract][Full Text] [Related]
22. Polymerase chain reaction-based clonality analysis of cutaneous B-cell lymphoproliferative processes.
Melotti CZ; Amary MF; Sotto MN; Diss T; Sanches JA
Clinics (Sao Paulo); 2010; 65(1):53-60. PubMed ID: 20126346
[TBL] [Abstract][Full Text] [Related]
23. [Diagnosis and classification of cutaneous pseudolymphoma. Historical review and perspectives].
Rijlaarsdam JU; Willemze R
Ann Dermatol Venereol; 1993; 120(1):100-6. PubMed ID: 8338321
[TBL] [Abstract][Full Text] [Related]
24. [Angiocentric cutaneous lymphoproliferative disorders].
Bachelez H
Ann Dermatol Venereol; 2000 Jan; 127(1):97-100. PubMed ID: 10717574
[No Abstract] [Full Text] [Related]
25. Differential diagnosis of cutaneous infiltrates of B lymphocytes with follicular growth pattern.
Leinweber B; Colli C; Chott A; Kerl H; Cerroni L
Am J Dermatopathol; 2004 Feb; 26(1):4-13. PubMed ID: 14726817
[TBL] [Abstract][Full Text] [Related]
26. Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement.
Kazakov DV; Kutzner H; Palmedo G; Boudova L; Michaelis S; Michal M; Vanecek T; Magro CM; Mukensnabl P; Dummer R; Burg G; Kempf W
Am J Dermatopathol; 2006 Oct; 28(5):399-409. PubMed ID: 17012914
[TBL] [Abstract][Full Text] [Related]
27. Cutaneous lymphomas.
Seçkin D; Hofbauer GF
Cancer Treat Res; 2009; 146():343-51. PubMed ID: 19415215
[No Abstract] [Full Text] [Related]
28. Cutaneous T-cell lymphoproliferative disorders: approach for the surgical pathologist: recent advances and clarification of confused issues.
Liu V; McKee PH
Adv Anat Pathol; 2002 Mar; 9(2):79-100. PubMed ID: 11917163
[TBL] [Abstract][Full Text] [Related]
29. Hyperplasia of hair follicles and other adnexal structures in cutaneous lymphoproliferative disorders: a study of 53 cases, including so-called pseudolymphomatous folliculitis and overt lymphomas.
Kazakov DV; Belousova IE; Kacerovska D; Sima R; Vanecek T; Vazmitel M; Pizinger K; Michal M
Am J Surg Pathol; 2008 Oct; 32(10):1468-78. PubMed ID: 18685486
[TBL] [Abstract][Full Text] [Related]
30. [Item 164--Malignant lymphomas: cutaneous lymphomas].
CEDEF
Ann Dermatol Venereol; 2012 Oct; 139(11 Suppl):A164-6. PubMed ID: 23176840
[No Abstract] [Full Text] [Related]
31. Cutaneous B cell lymphomas: standards in diagnostic and clinical work-up. Hints, pitfalls and recent advances.
Oschlies I; Wehkamp U
Histopathology; 2022 Jan; 80(1):184-195. PubMed ID: 34958501
[TBL] [Abstract][Full Text] [Related]
32. The role of MT2 and anti-bcl-2 protein antibodies in the differentiation of benign from malignant cutaneous infiltrates of B-lymphocytes with germinal center formation.
Chimenti S; Cerroni L; Zenahlik P; Peris K; Kerl H
J Cutan Pathol; 1996 Aug; 23(4):319-22. PubMed ID: 8864918
[TBL] [Abstract][Full Text] [Related]
33. Cutaneus pseudolymphoma: a case report.
Dragonetti E; Cianchini G; Mastrangelo L; Mellone P; Baldi A
In Vivo; 2004; 18(5):549-51. PubMed ID: 15523891
[TBL] [Abstract][Full Text] [Related]
34. bcl-2 protein expression and correlation with the interchromosomal 14;18 translocation in cutaneous lymphomas and pseudolymphomas.
Cerroni L; Volkenandt M; Rieger E; Soyer HP; Kerl H
J Invest Dermatol; 1994 Feb; 102(2):231-5. PubMed ID: 8106752
[TBL] [Abstract][Full Text] [Related]
35. Cutaneous pseudolymphomas: inflammatory reactive proliferations.
Hussein MR
Expert Rev Hematol; 2013 Dec; 6(6):713-33. PubMed ID: 24191857
[TBL] [Abstract][Full Text] [Related]
36. Iatrogenic Immunodeficiency-associated Lymphoproliferative Disorder Resembling B-cell Pseudo-lymphoma on the Lip and Conjunctivae.
Miyagawa F; Aoki Y; Hayashino A; Sotozono C; Asada H
Acta Derm Venereol; 2019 Jun; 99(7):683-684. PubMed ID: 30868170
[No Abstract] [Full Text] [Related]
37. Differential NFATc1 Expression in Primary Cutaneous CD4+ Small/Medium-Sized Pleomorphic T-Cell Lymphoma and Other Forms of Cutaneous T-Cell Lymphoma and Pseudolymphoma.
Magro CM; Momtahen S
Am J Dermatopathol; 2017 Feb; 39(2):95-103. PubMed ID: 27097342
[TBL] [Abstract][Full Text] [Related]
38. [Criteria for the differentiation of pseudolymphomas and malignant lymphomas of the skin].
Sterry W
Z Hautkr; 1986 May; 61(10):705-8. PubMed ID: 3716525
[TBL] [Abstract][Full Text] [Related]
39. Is Dermoscopy Useful for the Diagnosis of Pseudolymphomas?
Chessa MA; Filippi F; Patrizi A; Misciali C; Collina G; Savoia F; Pileri A
Dermatology; 2021; 237(2):213-216. PubMed ID: 32854093
[No Abstract] [Full Text] [Related]
40. Differential diagnosis of cutaneous large cell lymphomas using monoclonal antibodies reactive in paraffin-embedded skin biopsy specimens.
Beljaards RC; Meijer CJ; Scheffer E; van der Valk P; Willemze R
Am J Dermatopathol; 1991 Aug; 13(4):342-9. PubMed ID: 1928619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
